|
Apr 7
|
High Growth Tech Stocks To Watch In The US Market
|
|
Apr 7
|
AD/PD 2025: Long-term data shows Anavex’s Blarcamesine benefits in early Alzheimer’s
|
|
Apr 7
|
Anavex Life Sciences Reports Prolonged Benefit Data Of Blarcamesine In Early Alzheimer's Over 3 Years
|
|
Apr 5
|
Anavex Life Sciences Announces Positive up to 4-Years Oral Blarcamesine Results from Phase IIb/III Open-Label Extension Trial in Early Alzheimer’s Disease
|
|
Jan 21
|
Best Momentum Stocks to Buy for January 21st
|
|
Jan 6
|
Anavex Life Sciences to Present at the 43rd Annual J.P. Morgan Healthcare Conference
|
|
Dec 31
|
Are Medical Stocks Lagging Anavex Life Sciences (AVXL) This Year?
|
|
Dec 30
|
All You Need to Know About Anavex Life Sciences (AVXL) Rating Upgrade to Buy
|